Twist Bioscience Corporation (TWST) Return on equity 2019–2025
Twist Bioscience Corporation (TWST) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-16.4%FY2025 · since FY2019: -70.8% → -16.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16.4% | +27.7 pp |
| FY2024 | -44.2% | -11.3 pp |
| FY2023 | -32.8% | -5.2 pp |
| FY2022 | -27.6% | -1.4 pp |
| FY2021 | -26.2% | +15.4 pp |
| FY2020 | -41.6% | +29.2 pp |
| FY2019 | -70.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More TWST financial trends
TWST RevenueTWST Net incomeTWST Net marginTWST Gross profitTWST Gross marginTWST Operating incomeTWST Operating marginTWST Operating cash flowTWST Free cash flowTWST Capital expendituresTWST Stock buybacksTWST Dividends paidTWST Total assetsTWST Total liabilitiesTWST Shareholders’ equityTWST overview →